Key result
Effective antihypertensive treatment prevents the structural and functional changes associated with hypertension that lead to left ventricular hypertrophy and clinically overt heart failure.
Highlights the critical role of hypertension in the pathogenesis of heart failure and the importance of early antihypertensive treatment for prevention.
Supports early BP control to avert HF; leaves open optimal targets and agents for prospective trials.
Hypertension plays a key role in the evolution of the syndrome of heart failure. Hypertension has been identified as the chief precursor of left ventricular hypertrophy. Hypertensive left ventricular hypertrophy can lead to ventricular diastolic dysfunction; it is also a risk factor for myocardial infarction, which is a principal cause of left ventricular systolic dysfunction. Asymptomatic left ventricular dysfunction, whether systolic or diastolic, culminates in clinically overt heart failure when a threshold is exceeded or when other precipitating factors are superimposed. The onset of overt heart failure heralds a bleak outcome. These structural and functional changes associated with hypertension evolve over decades and are preventable with effective antihypertensive treatment. These observations emphasize the importance of early diagnosis and effective treatment of hypertension to prevent cardiac complications.
No takes yet. Share an insight, caveat, or question.
Ramachandran S. Vasan (1996) conducted a review in Hypertension and Heart Failure. Antihypertensive treatment was evaluated. Effective antihypertensive treatment prevents the structural and functional changes associated with hypertension that lead to left ventricular hypertrophy and clinically overt heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: